Description

SBICAP Securities Limited has listed new commercial paper worth Rs. 100 crore on BSE Debt segment with CRISIL A1+ and ICRA A1+ ratings, maturing on February 23, 2026.

Summary

SBICAP Securities Limited has listed new commercial paper worth Rs. 100 crore (2000 units of Rs. 5 lakh each) on the BSE Debt segment effective November 25, 2025. The commercial paper was issued on a private placement basis with a 91-day maturity period, carrying CRISIL A1+ and ICRA A1+ credit ratings. State Bank of India serves as the issuing and paying agent.

Key Points

  • Issue Size: Rs. 100 crore (2000 units)
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,845.50 per unit (discount of Rs. 8,154.50)
  • Scrip Code: 730637
  • Scrip ID: SSL241125
  • ISIN: INE212K14CS3
  • Credit Rating: CRISIL A1+ and ICRA A1+ (highest short-term rating)
  • Market Lot: 1 unit
  • Trading Denomination: Rs. 5 lakhs and multiples thereof
  • Tick Size: 1 paise
  • Trading Mode: Dematerialized form only

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for commercial paper issued on private placement basis.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE212K14CS3
  • Trading must be conducted in standard denominations of Rs. 5 lakhs and multiples thereof
  • All trades subject to tick size of 1 paise
  • For clarifications, trading members may contact BSE debt department at 22728352/8597/8995/5753/8915

Important Dates

  • Notice Date: November 25, 2025
  • Allotment Date: November 24, 2025
  • Listing Date: November 25, 2025
  • Redemption Date: February 23, 2026
  • Tenure: 91 days

Impact Assessment

Minimal market impact. This is a routine commercial paper listing that adds short-term debt instruments to the BSE Debt segment. The high credit ratings (A1+) indicate strong creditworthiness of the issuer. The instrument provides institutional investors with a short-term investment option with a 91-day maturity. No impact on equity markets or broader trading operations. State Bank of India’s role as issuing and paying agent provides additional credibility to the instrument.

Impact Justification

Routine commercial paper listing with no impact on trading members or investors beyond informational awareness. Standard debt instrument listing with high credit rating.